Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms.

about

Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms.

Item

http://www.wikidata.org/entity/Q38859362

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Socioeconomic burden of partic ...... myeloproliferative neoplasms.

@en

type

Item

label

Socioeconomic burden of partic ...... myeloproliferative neoplasms.

@en

prefLabel

Socioeconomic burden of partic ...... myeloproliferative neoplasms.

@en

P1476

Socioeconomic burden of partic ...... myeloproliferative neoplasms.

@en

P2093

Alessandra Iurlo

http://www.w3.org/2001/XMLSchema#string

Alessandro M Vannucchi

http://www.w3.org/2001/XMLSchema#string

Arturo Pereira

http://www.w3.org/2001/XMLSchema#string

Chiara Paoli

http://www.w3.org/2001/XMLSchema#string

Francisco Cervantes

http://www.w3.org/2001/XMLSchema#string

Swati Goel

http://www.w3.org/2001/XMLSchema#string

Tiziano Barbui

http://www.w3.org/2001/XMLSchema#string

P2860

Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

Patient-physician communication about out-of-pocket costs

Measuring the symptom burden associated with the treatment of chronic myeloid leukemia

Association of patient-provider communication domains with lung cancer treatment.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer.

Origins of socio-economic inequalities in cancer survival: a review.

Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program

Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.

P304

36-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12887

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayalew Tefferi

Fabio Efficace

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28370510

http://www.w3.org/2001/XMLSchema#string

P921

socioeconomics